Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025

Core Viewpoint - Biodesix, Inc. will release its financial results for Q1 2025 on May 13, 2025, and will host a conference call to discuss these results and provide a business update [1] Company Overview - Biodesix is a leading diagnostic solutions company focused on improving clinical care and outcomes for patients, particularly in lung disease [3] - The company markets diagnostic tests such as Nodify Lung® Nodule Risk Assessment and IQLung™ Cancer Treatment Guidance, which support clinical decisions for personalized care [3] - Biodesix also offers Diagnostic Development Services to biopharmaceutical, life sciences, and research institutions, enhancing their capabilities in developing diagnostic tests and therapeutics [3]